136 related articles for article (PubMed ID: 9713596)
21. Telomerase activity in human pleural mesothelioma.
Dhaene K; Hübner R; Kumar-Singh S; Weyn B; Van Marck E
Thorax; 1998 Nov; 53(11):915-8. PubMed ID: 10193387
[TBL] [Abstract][Full Text] [Related]
22. Telomerase Activation in Malignant Bone Tumors.
Wen J; Sun L; Zhang M; Zheng MH
Mol Diagn; 1998 Mar; 3(1):29-35. PubMed ID: 10096955
[TBL] [Abstract][Full Text] [Related]
23. Premature termination of telomeric extension-PCR for detection of telomerase activity.
Chen R; Qian J; Wang L; Mao YM
Biotechniques; 2003 Jul; 35(1):158-62. PubMed ID: 12866416
[TBL] [Abstract][Full Text] [Related]
24. Telomeric repeat amplification protocol: measuring the activity of the telomerase.
Xin H
Methods Mol Biol; 2011; 735():107-11. PubMed ID: 21461815
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
[TBL] [Abstract][Full Text] [Related]
26. Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy.
Lam KY; Lo CY; Fan ST; Luk JM
Mol Pathol; 2000 Jun; 53(3):133-6. PubMed ID: 10897332
[TBL] [Abstract][Full Text] [Related]
27. [Expression of telomere and telomerase in human primary gastric carcinoma].
Zhang F; Zhang X; Fan D
Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):429-32. PubMed ID: 11244953
[TBL] [Abstract][Full Text] [Related]
28. A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol.
Xu S; He M; Yu H; Cai X; Tan X; Lu B; Shu B
Anal Biochem; 2001 Dec; 299(2):188-93. PubMed ID: 11730342
[TBL] [Abstract][Full Text] [Related]
29. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol.
Hirose M; Abe-Hashimoto J; Ogura K; Tahara H; Ide T; Yoshimura T
J Cancer Res Clin Oncol; 1997; 123(6):337-44. PubMed ID: 9222300
[TBL] [Abstract][Full Text] [Related]
30. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
31. Telomerase, p53 and PCNA activity in osteosarcoma.
Nakashima H; Nishida Y; Sugiura H; Katagiri H; Yonekawa M; Yamada Y; Iwata H; Nagasaka T; Ishiguro N
Eur J Surg Oncol; 2003 Sep; 29(7):564-7. PubMed ID: 12943619
[TBL] [Abstract][Full Text] [Related]
32. Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme.
Szatmari I; Aradi J
Nucleic Acids Res; 2001 Jan; 29(2):E3. PubMed ID: 11139633
[TBL] [Abstract][Full Text] [Related]
33. Correlation of clinical features and telomerase activity in human gliomas.
Huang F; Kanno H; Yamamoto I; Lin Y; Kubota Y
J Neurooncol; 1999 Jun; 43(2):137-42. PubMed ID: 10533725
[TBL] [Abstract][Full Text] [Related]
34. [Telomere lengths and telomerase activity in liposarcomas].
Schneider-Stock R; Eppler C; Walter H; Radig K; Haeckel C; Hoang-Vu C; Epplen JT; Roessner A
Verh Dtsch Ges Pathol; 1998; 82():226-31. PubMed ID: 10095439
[TBL] [Abstract][Full Text] [Related]
35. Assessment and quantification of telomerase enzyme activity.
Maritz MF; Richards LA; Mackenzie KL
Methods Mol Biol; 2013; 965():215-31. PubMed ID: 23296661
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activity in 144 brain tumours.
Sano T; Asai A; Mishima K; Fujimaki T; Kirino T
Br J Cancer; 1998 May; 77(10):1633-7. PubMed ID: 9635839
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activity in malignant and benign bladder conditions.
Mayfield MP; Shah T; Flannigan GM; Hamilton Stewart PA; Bibby MC
Int J Mol Med; 1998 May; 1(5):835-40. PubMed ID: 9852304
[TBL] [Abstract][Full Text] [Related]
38. Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay.
Elmore LW; Forsythe HL; Ferreira-Gonzalez A; Garrett CT; Clark GM; Holt SE
Diagn Mol Pathol; 2002 Sep; 11(3):177-85. PubMed ID: 12218458
[TBL] [Abstract][Full Text] [Related]
39. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
40. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
